* Progyny Inc PGNY.OQ PGNY.O is expected to show a rise
in
quarterly revenue when it reports results on November 3.
* The New York City-based company is expected to report a
59.1% increase in revenue to $194.538 million from $122.28
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. The company's guidance on
August 4 2022, for the period ended September 30, was for
revenue between $190.00 million and $197.00 million.
* Refinitiv's mean analyst estimate for Progyny Inc is for
earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Progyny Inc
is
$57, above its last closing price of $43.89.
The company's guidance on August 4 2022 for the period ended
September 30 was for Earnings before Interest, Taxes,
Depreciation and Amortization of between USD190 million and
USD31.6 million.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.02 0.05 0.09 Beat 100
Mar. 31 2022 0.00 0.01 0.05 Beat 525
Dec. 31 2021 0.04 0.04 0.15 Beat 316.7
Sep. 30 2021 0.06 0.06 0.17 Beat 175.1
Jun. 0.08 0.08 0.19 Beat 131.7
30 2021
Mar. 31 2021 0.08 0.08 0.15 Beat 93.1
Dec. 31 2020 0.05 0.06 0.01 Missed -82.1
Sep. 30 2020 0.05 0.05 0.05 Met 4.6
This summary was machine generated November 2 at 02:05 GMT. All
figures in US dollars unless otherwise stated